Work

Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61

Year: 2020

Type: article

Source: Anti-Cancer Drugs

DOI: 10.1097/cad.0000000000000910

Authors: Taha Koray Sahin, Oktay Halit Aktepe, Fatih Mehmet Uckun, Suayib Yalcin

Institutions: Hacettepe University, Hacettepe University Hospital, University of Southern California, Children's Hospital Los Angeles

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: Amplifying Radiation Potency Against Leukemic Stem Cells, Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL, Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles

OpenAlex ID: W3006239533

FWCI: 0.281

Cites: 47

Cited by: 2

Related to: 10